Squarepoint’s Fulgent Genetics FLGT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$835K Sell
52,534
-3,668
-7% -$79.6K ﹤0.01% 2932
2025
Q4
$1.48M Buy
56,202
+6,915
+14% +$179K ﹤0.01% 2284
2025
Q3
$1.11M Buy
49,287
+22,809
+86% +$470K ﹤0.01% 2601
2025
Q2
$526K Sell
26,478
-60,707
-70% -$1.18M ﹤0.01% 3231
2025
Q1
$1.47M Buy
87,185
+45,577
+110% +$776K ﹤0.01% 2325
2024
Q4
$769K Buy
41,608
+26,659
+178% +$520K ﹤0.01% 3319
2024
Q3
$325K Buy
+14,949
New +$334K ﹤0.01% 3392
2023
Q3
Sell
-45,664
Closed -$1.69M 3932
2023
Q2
$1.69M Buy
+45,664
New +$1.59M 0.01% 1772
2022
Q1
Sell
-9,143
Closed -$920K 3072
2021
Q4
$920K Sell
9,143
-5,357
-37% -$471K ﹤0.01% 1750
2021
Q3
$1.3M Sell
14,500
-6,328
-30% -$575K ﹤0.01% 1414
2021
Q2
$1.92M Buy
+20,828
New +$1.66M 0.01% 1206
2021
Q1
Sell
-6,278
Closed -$327K 3272
2020
Q4
$327K Sell
6,278
-7,426
-54% -$310K ﹤0.01% 2139
2020
Q3
$549K Sell
13,704
-7,442
-35% -$233K 0.01% 1369
2020
Q2
$338K Buy
+21,146
New +$324K 0.01% 1533

Other funds holding FLGT